Scholarlink

<p>Psychosomatic is concerned with the complex interplay between the body, psyche and the social circumstances of an individual. In the clinical management of patients with gastrointestinal symptoms, this entails that the anamnesis, diagnostic assessment and treatment do not exclusively target somatic manifestations but also systematically address the emotional and social challenges inherent to the respective condition as well as potential comorbid psychiatric disorders and psychosocial stressors. Chronic inflammatory bowel disease (IBD) or disorders of gut-brain interaction (DGBA), such as irritable bowel syndrome (IBS), have been demonstrated in recent studies to significantly impair the quality of life and to impose considerable limitations on education, occupational functioning, leisure activities and interpersonal relationships. Furthermore, the prevalence of comorbid psychological disorders, particularly anxiety disorders and depression, is markedly elevated in patients with IBD and IBS compared to the general population. These comorbidities exert a&#xa0;negative effect on the course of gastrointestinal diseases, hospitalization rates and adherence to treatment regimens. Psychotherapeutic and clinical psychological interventions, gut-directed hypnosis and mindfulness-based approaches have demonstrated evidence-based efficacy predominantly in IBS. In the treatment of patients with IBD, these modalities provide a&#xa0;critical framework for addressing disease-associated psychosocial stressors, anxiety and depression, thereby substantially contributing to the enhancement of health-related quality of life.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Welcher Patient mit Magen-Darm-Beschwerden braucht psychosomatischen Support?

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月6日

查看全文
  • Bettina Keip,
  • Clemens Dejaco

摘要

Psychosomatic is concerned with the complex interplay between the body, psyche and the social circumstances of an individual. In the clinical management of patients with gastrointestinal symptoms, this entails that the anamnesis, diagnostic assessment and treatment do not exclusively target somatic manifestations but also systematically address the emotional and social challenges inherent to the respective condition as well as potential comorbid psychiatric disorders and psychosocial stressors. Chronic inflammatory bowel disease (IBD) or disorders of gut-brain interaction (DGBA), such as irritable bowel syndrome (IBS), have been demonstrated in recent studies to significantly impair the quality of life and to impose considerable limitations on education, occupational functioning, leisure activities and interpersonal relationships. Furthermore, the prevalence of comorbid psychological disorders, particularly anxiety disorders and depression, is markedly elevated in patients with IBD and IBS compared to the general population. These comorbidities exert a negative effect on the course of gastrointestinal diseases, hospitalization rates and adherence to treatment regimens. Psychotherapeutic and clinical psychological interventions, gut-directed hypnosis and mindfulness-based approaches have demonstrated evidence-based efficacy predominantly in IBS. In the treatment of patients with IBD, these modalities provide a critical framework for addressing disease-associated psychosocial stressors, anxiety and depression, thereby substantially contributing to the enhancement of health-related quality of life.